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ABSTRACT Human CYP27A1 is a mitochondrial cytochrome P450, which is principally found in the liver and plays important
roles in the biological activation of vitamin D3 and in the biosynthesis of bile acids. We have applied a systematic analysis of
hydrogen bonding patterns in 11 prokaryotic and mammalian CYP crystal structures to construct a homology-based model of
CYP27A1. Docking of vitamin D3 structures into the active site of this model identiﬁed potential substrate contact residues in the
F-helix, the b-3 sheet, and the b-5 sheet. Site-directed mutagenesis and expression in COS-1 cells conﬁrmed that these
positions affect enzymatic activity, in some cases shifting metabolism of 1a-hydroxyvitamin D3 to favor 25- or 27-hydroxylation.
The results suggest that conserved hydrophobic residues in the b-5 hairpin help deﬁne the shape of the substrate binding cavity
and that this structure interacts with Phe-248 in the F-helix. Mutations directed toward the b-3a strand suggested a possible
heme-binding interaction centered on Asn-403 and a structural role for substrate contact residues Thr-402 and Ser-404.
INTRODUCTION
The use of vitamin D3 by the body is mediated through a
series of mitochondrial cytochrome P450 enzyme reactions
in which the parent vitamin is transformed sequentially by
the hepatic 25-hydroxylase (CYP27A1) into 25-OH-D3 and
the renal 1a-hydroxylase (CYP27B1) into the active hor-
mone, 1a,25-(OH)2D3. Subsequent catabolism in vitamin D
target tissues by the 1a,25-(OH)2D3-inducible 24-hydroxy-
lase (CYP24A1) produces the biliary excretory product
calcitroic acid (1). The active hormone and its precursors are
transported between tissues complexed to vitamin D-binding
protein. In the nucleus of cells in vitamin D target tissues,
1a,25-(OH)2D3 binds vitamin D receptor to transactivate,
the expression of speciﬁc gene products affecting calcium
homeostasis and the proliferation and differentiation of
certain specialized cell types (2). Thus the structure of the
vitamin D molecule helps deﬁne crucial interactions with at
least ﬁve proteins, thereby inﬂuencing transport, activation,
biological action, catabolism, pharmacokinetics, and the pre-
cise sequence of these events (3). However, research into the
design of vitamin D prodrugs has shown that the activation
sequence can be manipulated, and that a nonphysiological,
1a-hydroxylated vitamin D analog can be 25-hydroxylated
and activated in a single cytochrome-mediated step (4).
The circulating level of 25-OH-D3 is a measure of vitamin
D status (5), but the CYP enzymes regulating its forma-
tion are still not completely deﬁned. The best studied 25-
hydroxylase, CYP27A1, is well conserved across species and
is a bifunctional enzyme that also expresses 27-hydroxylase
activity toward cholesterol and related sterols in two separate
bile acid biosynthetic pathways (6). Despite being the affected
target in cerebrotendinous xanthomatosis (CTX) (7,8), a
lipid storage disorder characterized by the accumulation of
abnormal metabolites of bile acid precursors (9), the only
indication of vitamin D deﬁciency associated with the loss of
CYP27A1 is an increased risk of osteoporosis and bone
fractures and in low 25-OH-D3 levels that fail to normalize
with bile-acid replacement therapy (10). This suggests a
redundant or compensatory 25-hydroxylase activity that is
in agreement with one of the earliest studies of vitamin D
25-hydroxylation, which inferred the existence of a high
speciﬁcity, low capacity (microsomal) enzyme and a low
speciﬁcity, high capacity (mitochondrial) enzyme (11). Two
of the candidates for the human microsomal 25-hydroxylase
include CYP3A4, a hepatic drug metabolizing enzyme with
broad substrate speciﬁcity (12,13), and CYP2R1, recently
shown to have activity (14) and to be associated with a mild
form of rickets (15). A similar microsomal 25-hydroxylase
redundancy is seen in the rat enzymes CYP2J3 (16),
CYP2R1, and CYP2C11 (17), the pig CYP2D25 (18), and
the mouse CYP2R1 (19).
Since there are no crystal structures of mitochondrial cyto-
chrome P450s, any model for CYP27A1 must be based
upon one or more existing prokaryotic or microsomal CYP
crystal structures. Although an important model of bovine
mitochondrial CYP11A1 (side-chain cleavage enzyme,
P450scc) (20) is available in the Protein Data Bank, there
is disagreement concerning the existence of an ad hoc sur-
face loop between the E- and F-helices hypothesized to
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mediate membrane binding in it since subsequent models
of bovine CYP11A1 (21), human CYP11A1 (22), human
CYP11B1 and CYP11B2 (23), and all cytochrome P450
crystal structures, including 14a-sterol demethylase (CYP51)
from Mycobacterium tuberculosis (24,25) and the mamma-
lian enzymes CYP2B4 (26), CYP2C5 (27,28), CYP2C8
(29), CYP2C9 (30), and CYP3A4 (31,32) show no evidence
of this surface loop. Thus the quality of a previous model for
CYP27A1 based on the original bovine model (7) remains in
doubt.
It is generally recognized that the multisequence align-
ment is a basic prerequisite for homology modeling. In the
case of the cytochrome P450 superfamily, obtaining a com-
prehensive alignment is difﬁcult because sequence homol-
ogies between families are typically 10–20%. We have
examined many P450 crystal structures, including a variety
of mammalian cytochromes from related families, and used
the observed secondary structure to reﬁne the multisequence
alignment process. This simpliﬁed the assignment of sec-
ondary structure in CYP27A1 to a degree that appears
superior to theoretical prediction. On further examination of
the crystal structures, we observed an extensive conservation
of hydrogen bonding patterns and structural motifs acting to
stabilize the folded structure. Consequently, this helped to
align less conserved residues that merely contribute to local
structure through backbone interactions. The cumulative
effect of well-deﬁned structural elements, extensive b-sheets
and conserved helices enabled an unprecedented reﬁnement
of the multisequence alignment.
We have used this systematic analysis of P450 crystal
structures to homology model CYP27A1 and to investigate
substrate contact residues in the binding cavity. Using
structure-guided, site-directed mutagenesis, we report the
effects of mutations in the F-helix, b-3 sheet, and b-5 hairpin
on the hydroxylation of the vitamin D prodrug 1a-OH-D3.
We have also used the model to examine substrate recog-
nition, the location of access channels in CYP27A1, and the
structure-function relationships associated with the poly-
morphisms giving rise to CTX (CYP27A1) and VDDR-I (in
CYP27B1) (1).
MATERIALS AND METHODS
Alignment and structural modeling
Protein sequences of selected cytochrome P450s and CYP crystallographic
templates retrieved from GenBank were aligned using ClustalX (33) and the
alignment edited manually using GeneDoc (34), according to observed
secondary structure. Structural coordinates retrieved from the Brookhaven
Protein Data Bank listed in Table 1 were aligned to the a-carbons of the
heme-thiolate cysteine and I-helix of P450cam using the LSQKAB structural
alignment utility (CCP4, Collaborative Computational Project, No. 4 Suite:
Programs for Protein Crystallography, University of York, Heslington, UK).
The aligned coordinates of P450bm3, P450cam, P450eryF, and P450terp were
superimposed to give a cage-like consensus framework into which the
human CYP27A1 sequence was threaded using Turbo Frodo (Architecture
et Fonction des Macromole´cules Biologiques-Centre National de la
Recherche Scientiﬁque, Marseille, France). This initial structure was
annealed through a series of extensively constrained geometry minimiza-
tions using Gasteiger-Marsili atom charges in SYBYL v6.8 (Molecular
Simulations, San Diego, CA). Constraints applied to maintain proper
hydrogen-bond lengths in the a-helices, b-sheets, structural motifs, and
hydrogen-bonding networks seen in 11 crystal structures were set to 2 A˚ and
gradually relaxed during extensive geometry optimizations. Molecular
dynamics simulations were performed using Insight II v2000 (Accelrys, San
Diego, CA) and RMSD calculations were made using PyMOL (DeLano
Scientiﬁc, San Carlos, CA). Ramachandran parameters were calculated with
PROCHECK (European Bioinformatics Institute, Cambridge, UK). Crystal
structures and models were visualized for detailed study using custom script
ﬁles written for Chime (Molecular Simulations) and PyMOL.
Substrate structures including vitamin D3, 1a-hydroxyvitamin D3,
cholesterol, and bile acid precursor 5b-cholestane-3a,7a,12a-triol were
retrieved from the Cambridge Crystallographic Data Centre and modiﬁed
and geometry optimized as required. The vitamin D structures were
manually docked with c25 and c27 constrained at 4 A˚ above the heme
A-ring nitrogen and cholesterol structures with c27 at 4 A˚ above the heme
A-ring nitrogen according to the position of c5 in camphor bound to
P450cam. For comparison, these structures were also docked in the binding
cavity using AutoDock v3.05 (Scripps Research Institute, La Jolla, CA).
Wild-type and mutant CYP27A1 structures used to assess the impact of each
mutation on substrate binding were energy minimized under identical
conditions (1000 iterations) from a single energy minimized structure.
Expression vectors and site-directed mutagenesis
Human CYP27A1 in pSG5 (4) was subcloned into the EcoRI-NotI site of the
C-terminal tag vector pcDNA3.1 His-V5-‘‘B’’ (Invitrogen, Carlsbad, CA)
after introduction of these ‘‘in frame’’ restriction sites by ampliﬁcation with
Taq polymerase (Qiagen, Mississauga, Ontario, Canada) and oligonucleotide
primers (Cortec DNA Service Laboratories, Kingston, Ontario, Canada) on a
PerkinElmer (Wellesley, MA) Thermocycler. Restriction enzymes and other
molecular biological reagents were obtained from Promega (Madison, WI)
and Amersham-Pharmacia (Baie d’Urfe, Quebec, Canada). After conﬁrmatory
sequencing (Cortec DNA Service Laboratories), both vectors were used in
site-directed mutagenesis reactions using a Chameleon Site-Directed Muta-
genesis Kit (Stratagene, LaJolla, CA). The list of primers is as follows:
Phe-248-Met, 59-CATAGAGTGAGTTCTGCATCATTAACCCGAT39.
Thr-402-Phe, 59-CCTTTTCTATGATCCGGGAGTTGAAGGGGACC-
ACAGGGTAGAG-39.
Asn-403-Thr, 59-CTATGATCCGGGAGGTTGTGGGGACCA-39.
TABLE 1 CYP crystallographic templates
Cytochrome P450 PDB coordinates
P450bm3 2hpd.pdb, 1bu7.pdb, 1fah.pdb, 1jpz.pdb
P450cam 1dz4.pdb, 1dz8.pdb, 1o76.pdb, 1pha.pdb
1phb.pdb, 1phd.pdb, 4cpp.pdb, 6cpp.pdb
1noo.pdb, 1mpw.pdb, 1lwl.pdb,1k20.pdb
lj51.pdb, 1iwi.pdb, 1gjm.pdb
P450eryF 1oxa.pdb, 1jio.pdb, 1jin.pdb, 1jip.pdb,
1egy.pdb, 1eup.pdb
P450terp 1cpt.pdb
CYP119 1f4u.pdb, 1f4t.pdb
CYP51 1ea1.pdb, 1e9.pdb, 1x8v.pdb
CYP2B4 1po5.pdb (closed), 1su0.pdb
CYP2C5 1nr6.pdb, 1n6b.pdb
CYP2C8 1pq2.pdb
CYP2C9 1og2.pdb, 1og5.pdb
CYP3A4 1w0e.pdb, 1w0f.pdb, 1w0g.pdb, 1tqn.pdb
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Ser-404Ala, 59-CCTTTTCTATGATCCGGGCGTTTGTGGGGACCA-
CAGG-39.
Ser-404-Thr, 59-CCTTTTCTATGATCCGGGTGTTTGTGGGGACCA-
CAGG-39.
Ile-514-Phe, 59-CTTATTGGGAACCAGGACAAAGCGGGCCA-CACT-
CTTCAACTC-39.
Val515-Ile, 59-CTTTCTTATTGGGAACCAGGATAATGCGGGCCA-
CA-CTCTTCAA-39.
Val-515-Leu, 59-CTTTCTTATTGGGAACCAGGAGAATGCGGGC-
CACACT-CTTCAA-39.
Leu-516-Val, 59-CTTATTGGG-AACCACGACAATGCGGGCC-39.
Site-directed mutations were veriﬁed by sequencing and the vectors puriﬁed
using Wizard Maxi-prep resin (Promega). The Phe-248-Met, Thr-402-Phe,
Asn-403-Thr, and Leu-516-Val mutations were transfected in the pSG5-
CYP27A1 vector, whereas the Ser-404-Ala, Ser-404-Thr, Ile-514-Phe,
Val-515-Ile, and Val-515-Leu mutations were transfected in the pcDNA3.1-
CYP27A1 vector.
COS-1 transfection
African green monkey kidney COS-1 cells (ATCC CRL-1650) were grown on
Nunc cell culture dishes using Dulbecco’s modiﬁed Eagle’s medium and
13 antibiotic-antimycotic (Gibco-BRL Canadian Life Technologies, Burling-
ton, Ontario, Canada) supplemented with 10% CELLect Gold fetal bovine
serum (ICN, Costa Mesa, CA) at 37C. COS-1 cells were transiently
cotransfected on 150 mm plates by the DEAE-dextran method (35) using a
plasmid cocktail containing10mg each ofCYP27A1wild-type ormutant vector
and vectors expressing bovine ferredoxin (pEAdx) (36), and ferredoxin
reductase (pEAR) (37); 3 mg of a ﬁreﬂy luciferase expression plasmid
(pRSVLuc)were included as a transfection control in each cocktail. Transfected
cells were allowed to recover overnight in supplemented medium and
subcultured onto triplicate 100mmplates 1 day beforeCYP27A1 activity assay.
Vitamin D compounds
1a-OH-D3 and 1a,25-(OH)2D3 were gifts of Drs. Ernst Binderup and Anne-
Marie Kissmeyer (Leo Pharmaceuticals, Ballerup, Denmark). Reference
compound 1a,26-(OH)2D3 was synthesized and generously provided by
Dr. Martin Calverley (Leo Pharmaceuticals).
CYP27A1 activity assay
Transfected COS-1 cells were cultured to late log phase, washed with 10 mL
phosphate-buffered saline, and then incubated with 10 mL incubation
medium/dish containing Dulbecco’s modiﬁed Eagle’s medium, 1% bovine
serum albumin (Boehringer-Mannheim/Roche Diagnostics, Laval, Quebec,
Canada), 13 antibiotics, 100 mM N,N-diphenylethylenediamine as an
antioxidant (Sigma-Aldrich, Oakville, Ontario, Canada), 40 mg (10 mM) 1a-
OH-D3, and 0.02% ethanol for 48 h. No-cell and dead-cell controls consisted
of, respectively, an empty dish or dead cells (microwave treated) incubated
as above. The incubation medium was extracted to isolate vitamin D
compounds in the total lipid fraction using a modiﬁcation of the method of
Bligh and Dyer (38) in which chloroform was replaced by dichloromethane.
The organic layer was evaporated to dryness under a stream of nitrogen,
redissolved in hexane/isopropanol/methanol (91:7:2 v/v/v) and subjected to
separation by HPLC (39).
High performance liquid chromatography
Straight-phase HPLC (40,41) was performed using Millennium32, an
Alliance 2690 Separations Module, and a model 990 photodiode array
detector (Waters Associates, Milford, MA). Vitamin D metabolites were
separated on Zorbax-SIL (3 m, 6.2 3 80 mm) columns using hexane/
isopropanol/methanol 91/7/2 at a ﬂow rate of 1 mL/min. and identiﬁed by
the characteristic ultraviolet absorption spectrum of the triene chromophore
(lmax ¼ 265 nm). Retention times of metabolites varied on the different
columns used. Metabolite peak areas were normalized to an HPLC internal
standard (2 mg 25-OH-D3) and to the cell transfection efﬁciency, the latter
determined from luciferase activity measurements acquired using cell
culture lysis buffer, single luciferase assay reagents (Promega), and a
Microlumat LB96V microplate luminometer (EG&G Berthold, Bad Wild-
bad, Germany).
RESULTS
Aligning the sequences
The observed a-helices, b-sheet, and loop secondary struc-
ture in eleven CYP crystallographic templates was used to
manually parse the sequences in the alignment shown in
Fig. 1. Gaps were introduced into the alignment to highlight
these secondary structures. This revealed many functionally
equivalent residues and conserved backbone interactions
within secondary structures and tertiary structural motifs.
Further reﬁnements were made by systematically cataloging
conserved hydrogen bonding patterns in the templates as
shown in Figs. 2 and 3. As described below, there was ex-
tensive conservation of b-sheet structure and hydrogen bond-
ing networks across all templates. The reﬁned alignment was
used to assign secondary structure in seven uncharacterized
CYPs, including CYP27A1, using size of structural element,
sequence homology, and side-chain polarity.
Modeling the N-terminus region
CYP27A1 is expressed with a 33-residue amino terminal
mitochondrial targeting sequence containing seven separated
basic residues. Cleaved during mitochondrial import, the
resulting mature protein begins at residue 34 with a hydro-
philic, arginine-rich patch (Arg-51, Arg-52, Arg-53, Gln-54,
Arg-55) preceding a conserved proline (Pro-61). Unfortu-
nately, since none of the templates contain an analogous
structure for this sequence, we extrapolated the N-terminal
region back to Arg-53 to ﬁnd that the arginine-rich patch
could be within hydrogen bonding distance of polar residues
between the B-B9 loop (e.g., Asn-128) and b-1 (e.g., Gln-
103) on b-3b (e.g., Gln-423) and the F-G loop, suggesting
possible inﬂuence on substrate access. The position of Pro-
61 is predicted in 7 out of 11 (7/11) templates as the ﬁrst
proline in a PGP motif of a larger proline-rich sequence
required for proper folding and heme incorporation in
CYP27A1 and CYP11A1 (40) and in rat CYP2C11 where it
may have been inadvertently disrupted experimentally due to
a sequence alignment error (41). It is also the site of two
P450 deﬁciency polymorphisms (P42S in CYP11B1 and
P30L in CYP21B1). As shown in Fig. 2, the proline amide
carbonyl forms a conserved hydrogen bond to the same b-1
sheet amide nitrogen position in 7/11 templates or an
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equivalent interaction to the same b-1 residue position in 2/4
of the remaining templates. This helps orient a hairpin
structure between the PGP motif and the A9-helix region in
7/11 templates. Postulated to form a folding nucleus (42), the
PGP motif and surrounding structure may also inﬂuence
active site structure and a substrate access channel through in-
teractions with the F-G loop and the A9-helix region.
Shielding and contacting part of the substrate binding site,
the sequence along the 14–15 amino acid length of the
A-helix is, for a given CYP, well conserved across species.
A conserved glutamine in the middle of the CYP27A1
and CYP27B1 A-helix corresponds to a VDDR-I mutation
(Q65H in CYP27B1). The orientation of the A-helix depends
on CYP-speciﬁc polar interactions with the b-3 and b-5
sheets and the presence of a tyrosine-glycine pair at the
A-helix terminus. The b-1 sheet begins at the end of the
A-helix and is distinguished by a glycine at the b-1 hairpin
and the pattern of hydrogen bond conservation seen in Fig. 3.
Although conserved in the smaller b-1 sheet of the ther-
mophile CYP119, what is especially remarkable about this
pattern is how it integrates seamlessly through the b-3 sheet
and B-B9 loop to two major heme-binding residues in all
templates. In fact, this extended b-sheet encompasses con-
served connections through the b-5 sheet to the D-E loop and
across one side of the active site through the B-B9 loop to the
B9-C loop.
FIGURE 1 Multisequence alignment of CYP27A1, CYP27B1, CYP24A1, CYP11A1, CYP11B2, CYP17, and CYP21B1. Primary sequences were parsed
and secondary structure predictions assigned using the observed secondary structure and conserved hydrogen bonding patterns seen in eleven CYP
crystallographic templates. Shaded positions with dark text denote similar residues conserved in at least 9 of 18 aligned sequences. Shaded positions with white
text and marked with ‘‘*’’ and ‘‘#’’ denote heme-binding and ERR-triad residues, respectively. Residues in the b-sheets structurally positioned toward
substrate recognition in a pw2a access channel are denoted by ‘‘§’’. Residues mutated in this study are indicated with white text on black and identiﬁed by
lower case letters: a, Phe-248-Met; b, Thr-402-Phe; c, Asn-403-Thr; d, Ser-404-Ala, Ser-404-Thr; e, Ile-514-Phe; f, Val-515-Ile, Val-515-Leu; and g, Leu-516-
Val. Sites of missense mutations causing cerebrotendinous xanthomatosis (CYP27A1), vitamin D-dependency rickets (CYP27B1), and autosomal deﬁciencies
in CYP11B1, CYP17, and CYP21B1 are also indicated with white text on black shading. Gaps within secondary structures were added to emphasize
structurally important landmarks.
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Incorporating the heme into a structural network
The heme-binding region is a rigid network of 20 or more
hydrogen bonds and structural waters seen in Fig. 4, a–c, to
connect the heme A- and D-ring propionates to the B-/B9
loop, B9-C loop, C-helix, b-3 sheet, and heme-thiolate loop.
First described in P450Bm3, P450cam, and P450terp (43), the
heme-binding region is remarkably conserved in all tem-
plates with functionally equivalent residues occupying an ex-
clusive space and making an equivalent contribution. Careful
maintenance of these heme-binding interactions during
energy minimization stabilizes important substrate contact
residues in adjacent structures.
Situated on the proximal side of the heme, the B-helix
contains polar residues directed toward the protein surface
and cofactor binding and hydrophobic residues directed
inward toward the b-3 sheet. The B-helix ﬂanks the heme-
thiolate loop (containing the conserved cysteine thiol) and
structurally supports it through a hydrogen bond between the
penultimate B-helix residue carbonyl and the3thiolate amide
nitrogen (Fig. 4 a). In some of the templates, this hydrogen
bonding appears to be mediated by structural waters, as
shown in Fig. 4 b for 12 superimposed P450cam structures.
Disruption of this interaction in CYP2R1 by an inactivating
Leu-99-Pro polymorphism abolished all 25-hydroxylase
activity toward vitamin D3 and left a small residual activity
toward vitamin D2 (15). The mutation of the analogous
residue in CYP51 (F105L) arose clinically in ﬁve Candida
albicans isolates as ﬂuconazole resistance (44). That struc-
tural integrity in this region is important is further illustrated
by a CAH polymorphism (G424S in CYP21B1) at the
4thiolate position.
The heme iron is axially coordinated by the conserved
cysteine thiol on the proximal side of the heme. This thiolate
bond is stabilized by the surrounding residues, with the
sulfur atom being nearly equidistant from the 11thiolate,
12thiolate, and13thiolate amide nitrogens, and the tight turn at
12thiolate into the L-helix probably accounts for the near
absolute conservation of glycine at this position. As shown
FIGURE 1 Continued
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in Fig. 4 a, the heme-thiolate loop is stabilized by four con-
served hydrogen bonds:1thiolate amide nitrogen to4thiolate
amide carbonyl; 6thiolate amide nitrogen to 9thiolate amide
carbonyl; cysteine amide carbonyl to 13thiolate amide nitro-
gen; and cysteine amide nitrogen to 7thiolate amide car-
bonyl, the latter being a highly conserved phenylalanine
inﬂuencing heme reduction potential (45). The heme-thiolate
loop is further constrained by hydrogen bonds between a
C-helix arginine (Arg-158 in CYP27A1) and the 1thiolate
amide carbonyl in 9/11 templates (Fig. 4 c). This C-helix
arginine also hydrogen bonds with the D-ring propionate, but
the main C-helix to D-ring propionate link involves trypto-
phan one turn earlier (Trp-154 in CYP27A1) in the mito-
chondrial CYPs and 6/11 templates. In the remaining ﬁve
templates, an equivalent polar side chain (arginine, gluta-
mine, or histidine) is hydrogen bonded to the D-ring pro-
pionate, and in three of these it is also hydrogen bonded to
3thiolate amide carbonyl.
Another hydrogen bond to the D-ring propionate is made
by the 2thiolate arginine (or histidine in CYP119, CYP51,
P450cam, P450eryF, and P450terp) and mutation of this side-
chain disrupted heme incorporation and enzyme activity in
CTX (R474Q, R474W), VDDR-I (R453C), and P450 deﬁ-
ciency polymorphisms (R448H in CYP11B1, R440H in
CYP17A1, and R426H in CYP21B1). The2thiolate arginine
also hydrogen bonds to amide carbonyls of key substrate
contact residues in the B9-C loop and to the side chain at the
start of the C-helix (Glu-150 in CYP27A1; Fig. 4 c). The
latter is the site of a P450 deﬁciency polymorphism (N133H
in CYP11B1) and the aspartate, glutamate, or asparagine
side chain found there is bonded to the backbone of the B-B9
loop at precisely the location of a conserved arginine (aspar-
agine, lysine, or serine in the prokaryotic templates). This
B-B9 loop arginine hydrogen bonds to the A- and D-ring
propionates, a fact that was not fully appreciated until
CYP2C5 and other eukaryotic structures became available.
B-B9 loop arginine is the site of CTX (R127Q and R127W),
VDDR-I (R107H), and CAH (R96W in CYP17A1) poly-
morphisms. In all other templates, the hydrogen bonding
of the aligned residue (asparagine, lysine, or serine) to the
A-ring propionate is mediated through the nearby b-3
‘‘heme-binding’’ arginine. The B-B9 loop is connected to the
11b3Arg by two b-sheet bonds in all templates. Polymor-
phisms affecting b-3 arginine cause CTX (R405Q, R405W),
VDDR-I (R389C, R389G, R389H), and P450 deﬁciency
(R384P in CYP11B2) because they disrupt a major structural
link (usually a bidentate salt bridge) to the A-ring propionate.
Conserved in the mitochondrial, bacterial (except P450bm3),
and CYP3A4 enzymes, b-3 arginine is replaced by proline1
FIGURE 2 Hydrogen bonding patterns in the N-terminal domain of
selected CYP crystallographic templates. Although the structure of the
N-terminal domain is highly variable, a conserved hydrogen bond is seen in
most templates between a conserved proline amide carbonyl and the amide
nitrogen of an aligned b-1 residue. This proline is part of a PGP-motif or
larger proline-rich domain found in many P450s but seen as Pro-61, Arg-62,
and Leu-63 in Cyp27A1. This proline provides a useful landmark for
alignment and modeling and helps position a highly structured hairpin near
the b-1 sheet. Relative to this proline landmark, a hydrogen bond is seen
from the 3proline amide carbonyl to the b-4 sheet in 4/11 templates. Other
hydrogen bonds stabilize this hairpin through 15proline to 19proline double
backbone interaction and a 18proline amide carbonyl to 111proline amide
nitrogen. Additional hydrogen bonds connect the 110proline backbone and
side chain (usually asparagine) to the 12proline and 13proline backbone and
the amide nitrogen at a conserved position in the b-1 sheet position. The
aligned 11proline and 12proline positions were repeated in the ﬁgure for
clarity. Notes: i), hydrogen bonding patterns in CYP2C8, CYP2C9, and
CYP3A4 are similar to CYP2B4 and CYP2C5; and ii), solid lines indicate
backbone hydrogen bonds between amide nitrogen and amide carbonyl
(indicated by an arrowhead). Double arrows indicate the presence of two
backbone hydrogen bonds between the indicated residues. Dashed lines
indicate hydrogen bonds involving side chains, and those interacting with
amide nitrogen are marked with a small font ‘‘N’’. Diamond placeholders
indicate positions of aligned residues not involved in structural hydrogen
bonding interactions.
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histidine in the CYP2 templates. In many microsomal CYPs,
this histidine binds heme by bridging the A-ring propionate
to the B-B9 loop. In all enzymes with b-3 arginine though,
the side chain is hydrogen bonded to both 1b3Arg amide
carbonyl and via structural water to the penultimate B-helix
carbonyl.
Other heme-binding interactions in the network are directed
toward the A-ring propionate. Hydrogen bonds from the
1b3Arg amide nitrogen are seen in CYP51 (Met-325
mediated by Tyr-76), P450bm3 (Ser-332 via water),
P450eryF (Thr-292 via water), and CYP3A4 (Glu-374 via
water), through the1b3Arg amide carbonyl in P450bm3 (Ser-
332 via water) and CYP2 templates (proline amide carbonyl
mediated through B-B9 loop arginine). In the other tem-
plates, the 2b3Arg side chain hydrogen bonds to the A-ring
propionate, and this interaction is further stabilized by a side
chain in the second b-3 strand. In CYP2C5, this corresponds
to Asn-362 and 121b3Arg side chain (Thr-386), in P450cam
FIGURE 3 Conserved backbone hydro-
gen bonding patterns in the extended
b-sheet of eight selected crystal structures.
As shown, there are 4–6 conserved hydro-
gen bonds between adjacent strands of the
b-1 andb-3 sheets. The shortened b-1 struc-
ture seen in the thermophillic archaeon
CYP119 crystal structure retains the align-
ment of four out of ﬁve hydrogen bonds
despite a four-residue truncation. Num-
bered positions denote distance from the
heme-binding b-3 arginine or histidine-
proline pair. The heme-binding residue in
the b-3a strand hydrogen bonds to the heme
A-ring propionate in all structures except
P450Bm3, where the interaction is mediated
through structural waters to the amide nitro-
gen and carbonyl of the adjacent residue, Ser-
332. The symbols used are noted in Fig. 2.
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as Asp-297 and 123b3Arg (Gln-322), and in P450eryF
123b3Arg (Asn-316). This 2b3Arg and123b3Arg side-chain
interaction with the A-ring propionate is especially relevant
since the corresponding residues, Asn-403 and His-428
in CYP27A1, are completely conserved across species. In
P450terp, the 123
b3Arg side chain (Tyr-342) hydrogen bonds
to the A-ring propionate directly. In all templates, another
hydrogen bond to the A-ring propionate is made from the
heme-thiolate loop by 5thiolate amide nitrogen. This is me-
diated by a structural water in all templates except P450terp
FIGURE 4 Stereo images of hydrogen bonding patterns in CYP27A1. Panel a shows heme-binding interactions with the heme propionates from residues in
the heme-thiolate loop, b-3a strand, and B-B9 loop. The heme-thiolate loop is stabilized through a conserved hydrogen bond between the B-helix and the
3thiolate amide nitrogen. The hydrogen bond seen between the 6thiolate amide carbonyl and the A-ring propionate should be interpreted as an interaction
between the 5thiolate amide nitrogen and the A-ring propionate, which is mediated by a structural water. The conservation of structural waters in the heme-
binding region is illustrated in panel b, where selected crystallographic waters from 12 P450cam structures are colored differently and superimposed to reveal
the conserved interactions with the 5thiolate amide nitrogen (His-352) and other stabilizing interactions with the heme-binding region. Panel c further
illustrates how residues in the B-B9 loop, B9-C loop, C-and I-helices, b-3 sheet, and the heme-thiolate loop contribute to the hydrogen bonding in the heme-
binding region in CYP27A1. Panel d shows the hydrogen bonding at the junction between the E- and H-helices that is conserved in 10/11 templates and
mediated through the interaction of a basic G-helix residue with the conserved aspartate (Asp-303) at the beginning of the H-helix. The structural contribution
of the Asp-84, Glu-215, and Arg-225 interaction to the stability of the E-F loop in CYP27A1 resembles similar interactions seen in the CYP2 templates. This
panel also illustrates the position of a putative disulﬁde bond and a cavity analogous to a xenon-binding pocket seen in P450cam (49). Panel e shows the
conserved hydrogen binding network surrounding the ERR-triad and a well conserved structural link to the start of the B-helix. Also shown is a well-conserved
link between the J-helix Glu-354 and the K-helix.
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(which bonds directly) and the CYP2 templates (mediated
by the 6thiolate serine side chain).
The rigid structure of the heme-binding region is contin-
uous with the B9-C loop in all templates (except CYP51,
which is atypical), and this helps to position a critical substrate
contact residue (Phe-147 in CYP27A1) above the D-ring
propionate. Irrespective of B9-helix variability, the B9-C loop
assumes a well-deﬁned structure in the vicinity of a conserved
glycine in 6/11 templates and at similarly aligned residues in
other CYPs. The structural importance of the B9-C loop
glycine in orienting the substrate contact residue is revealed in
the existence of CTX (G145E) and VDDR-I (G125E)
polymorphisms and in a study of inactivating site-directed
mutants: G145A and G125A/V, respectively (46). The B9-C
loop is internally stabilized through hydrogen bonding of the
glycine amide carbonyl to 14B9Cglycine amide nitrogen in
P450bm3, CYP2B4 and CYP3A4, to14
B9Cglycine side chain in
the CYP2C templates, and to 13B9Cglycine amide nitrogens in
4/6 prokaryotic templates. In the same prokaryotic templates,
stability is further enhanced by a 11B9Cglycine amide carbonyl
to 14B9Cglycine amide nitrogen interaction. Spatially, the
B9-C loop is oriented through conserved hydrogen bonds
with adjacent structures. This includes B-B9 loop arginine
(or equivalent) to 12B9Cglycine amide carbonyl (9/11 tem-
plates), 2thiolate arginine (or histidine) to 11B9Cglycine and
14B9Cglycine (10/11 templates), and an I-helix aspartate in
CYP2C templates hydrogen bonded to 11B9Cglycine and
12B9Cglycine amide nitrogens. The latter I-helix interaction
was deduced in CYP2D6 (47), and a functionally equivalent
link between the I-helix and B9-C loop is seen in CYP3A4 and
at least 3/6 prokaryotic templates. In fact, the alignment of a
conserved glutamate at this position (Glu-331 in CYP27A1)
in the mitochondrial vitamin D hydroxylases and aspartate or
glutamate in many other mammalian CYPs (e.g., CYP2C11,
CYP2J3, CYP2R1, CYP11, CYP17, and CYP21) further
emphasizes the importance of a structural link between the
I-helix and the B9-C loop.
Building the EH-gap motif, E-F loop, and
a putative disulﬁde
Adjacent to the C-D loop is a highly structured region
encompassing the end of the E-helix and the start of the
H-helix. As shown in Fig. 4 d, two hydrogen bonds bridge
the gap to join aligned residues and create the effect of a
continuous helix in 10/11 templates. Centered on the inter-
action of a conserved aspartate at the start of the H-helix with
a basic side chain four residues from the end of the G-helix,
this EH-gap motif established these two residues as impor-
tant landmarks in the alignment and positions the end of
the G-helix. The EH-gap also contributed to the presence of
a small cavity in the model similar to one recognized as a
xenon binding site in P450cam (48,49).
In the CYP2 templates, where the E-F loop is long enough
to parallel the D- and E-helices, hydrogen bonding residues
near the middle of each helix interact with the second residue
in the E-F loop (usually arginine) to further stabilize the
region. Fig. 4 d shows this interaction in CYP27A1 with
Asp-164 (D-helix), Arg-225 (E-F loop), and Glu-215
(E-helix). These residues are very well conserved in the vitamin
D hydroxylases where the aspartate is the site of a VDDR-I
mutation (D164N) and the glutamate is adjacent to a CTX
mutation (A216P). Although the latter may be splicing
mutant (50), it is also adjacent to Ile-217, which aligns with
the most common mutation site in CYP21B1-related CAH
deﬁciency (I172N) (51). The E-helix backbone near this
Ile-217 is part of a small hydrogen bonded network in all
templates that joins the I-helix oxygen binding site to a con-
served L-helix glutamate (asparagine or glutamine) through
a structurally conserved water molecule. Other structurally
important landmarks nearby include the aspartate at the
beginning of the E-helix (8/11 templates) and the conserved
hydrogen bonds between the b-5 sheet and D-E loop.
The establishment of hydrogen bonding interactions to
anchor the E-F loop in the model of CYP27A1 exposed a
possible disulﬁde bond with the E-helix involving Cys-218
and Cys-228 (Fig. 4 d). These cysteines are conserved in
CYP27A1 from human, dog, pig, rat, rabbit, baboon, and
Xenopus, but the latter cysteine has been lost in bovine,
chicken, mouse, and fugu. In addition to CYP27A1, there
may be two disulﬁdes in CYP27B1 (human) and three in
CYP24A1 (human, pig, and rat). The possibility of native
disulﬁde bonds in cytochrome CYPs has never been ad-
dressed before despite multiple possibilities associated with
the D- and E-helices in CYP2C5, CYP2C8, and CYP2C9.
Interestingly, one introduced into P450cam by site-directed
mutagenesis appears to have connected the B9- and G-helices
to affect substrate access and egress channels (49).
Positioning the F-helix
The alignment of the F-helix beneﬁted signiﬁcantly from
detailed examination of the templates. Although the F-helix
begins with an aspartate in 8/11 templates, neither it nor an
apparently conserved phenylalanine in 9/11 templates was
spatially conserved outside of P450bm3, CYP51, and the
CYP2 templates. Thus the alignment of the F-helix for
CYP3A4 and the prokaryotic templates in Fig. 1 is based on
a spatially conserved a-carbon corresponding to CYP2
template phenylalanines. On the basis that the phenylalanine
is conserved across species in the mitochondrial CYPs, the
alignment of Phe-240 in CYP27A1 was used to model the
height and spin orientation of the F-helix.
Linking the J-, K-, and L-helices
The alignment and modeling of the I- and J-helices was
essentially unremarkable. The abrupt turn of the I-helix into
the J-helix, however, is punctuated by sites of CTX (D354G)
and VDDR-I (R335P) mutations. A second VDDR-I locus in
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the J-helix (L343F) is directed toward the K-helix. The
structural disruption mediated by these mutations became
apparent only after a conserved glutamate side chain (aspartate
in P450eryF and P450terp) was found to be hydrogen bonded
with conserved amide nitrogen(s) near the start of the K-helix
in 9/11 templates. Disruption in CYP27A1 of this J- to
K-helix link (involving the J-helix Glu-364 side chain and the
K-helix Leu-385 and Leu-386 amide nitrogens), shown in
Fig. 4 e, by an adjacent CTX mutation (P384L) probably
destabilizes the J- and K-helices and J-K loop.
Two of four CAHmutations (P342T, R347H in CYP17A1
and R339H, R341W in CYP21B1) seen in the J-K loop
correspond to a residue involved in a four-part hydrogen
bonding network connecting the K- and L-helices in the
CYP2 templates (three-part in CYP2C9). Three side chains
of this four-part network in CYP2B4, CYP2C5, and
CYP2C8 align with essential cationic charges in CYP17A1
necessary for lyase activity (52). Three side chains in this
four-part network also align with residues that appear to
provide a functionally equivalent four-part interaction in the
vitamin D hydroxylases (Lys-387, Lys-391, Glu-483, and
Gln-487). Overall, functionally equivalent KL-motifs are
seen in 10/11 templates and appear to be very well conserved
in the mitochondrial vitamin D hydroxylases and may
stabilize a P450cam-type xenon binding pocket above it (49).
Building the ERR-triad
Integral to the interactions of the K-helix with surrounding
secondary structures is its participation in the ERR-triad.
Continuous with the b-3a strand, the K-helix also anchors
the ERR-triad to the heme-region, the substrate-binding site,
and the extended b-sheet. At the center of the ERR-triad, the
conserved glutamate (Glu-392) and arginine (Arg-395)
appearing as a ExxR motif in the K-helix (11/11 templates)
are hydrogen bonded to an arginine (Arg-448) in the meander
region of 7/11 templates or histidine in CYP2 templates.
Originally described as ‘‘a structureless wandering of ;20
amino acids’’ (43), the meander region contains some of the
16 residues preceding the arginine (Arg-448) that enveloped
the ERR-triad in a highly coordinated hydrogen bonding
network ﬁrst described in P450Bm3, P450cam, and P450terp
(43) and viewed in the CYP27A1 model shown in Fig. 4 e
and depicted in Fig. 5. A pervasive structural element seen
in all P450s, the ERR-triad may act as a folding motif,
stabilize heme-binding, and play a role in redox-partner
binding (43). It also anchored the start of the B-helix from a
conserved aspartate numbered14 from the meander arginine
in all templates except in CYP51 where the aspartate is at
position 11.
Contribution of Phe-248 to the binding cavity
The F-helix forms the top of the binding cavity and contains
a number of residues that are conserved in a subfamily-
speciﬁc fashion. Phe-248 was selected for mutagenesis since
it is conserved across species in all mitochondrial CYPs
except CYP24A1 (conserved there as methionine) and was
seen in the model to contribute a hydrophobic surface to the
binding cavity. Although direct contact with substrate is
possible, Phe-248 is positioned high above the heme at the
back of the cavity where it could inﬂuence the shape of the
b-5 hairpin or interact with residues near the conserved
threonine in the I-helix. The mutation to methionine was
chosen to mimic CYP24A1, and although Phe-248-Met did
not confer any 24-hydroxylase-like activity, it did preferen-
tially reduce 25-hydroxylase activity (Fig. 6 a). Table 2
shows how the 1a,25-(OH)2D3 to 1a,27-(OH)2D3 product
ratio shifted from wild-type 49:36 to mutant 42:43. Interest-
ingly, Pikuleva et al. also experimented with Phe-248 (their
numbering; F215) and Ile-244 (I211) using lysine scanning
and demonstrated that either mutant decreased turnover
number and caused a minor accumulation of novel metab-
olites from the bile acid precursor substrate 5b-cholestane-
3a,7a,12a-triol (53). Annalora et al. experimented with a
nearby phenylalanine in rat CYP24A1 (Phe-249), which aligns
with Ser-251 in CYP27A1, and concluded that mutation to
alanine, threonine, or tyrosine disrupted the orientation and
afﬁnity of 24-oxidation intermediates in the multicatalytic
oxidation sequence converting 1a,25-(OH)2D3 to calcitroic
acid. It was postulated that phenylalanine contact with the
vitamin D cis-triene was the determining factor in the ac-
cumulation of pathway intermediates (54). Overall, these
studies suggest that the part of the F-helix around Phe-248
FIGURE 5 Schematic view of the hydrogen bonding network in the ERR-
triad. Shaded dashed lines indicate conserved hydrogen bonds between the
triad residues and the surrounding backbone. Numbering in the K-helix is
relative to the conserved glutamate, and numbering in the structure sur-
rounding the triad is relative to the conserved arginine (histidine in CYP2
templates) near the start of the meander region. The thin dashed lines
indicate additional side-chain interactions that stabilize the loop/helix
structure at the end of the b-3b strand and the link to the B-helix.
3398 Prosser et al.
Biophysical Journal 90(10) 3389–3409
FIGURE 6 HPLC analysis of 1a-OH-D3 metabolites from COS-1 cells transiently transfected with wild-type and site-directed mutants of CYP27A1 and
stereo views of the targeted mutations with docked substrate in the binding cavity. (a) Proﬁle of metabolites from the Phe-248-Met mutant show a preferential
loss in 25-hydroxylase activity with reduced 1a,25-(OH)2D3 formation relative to 1a,27-(OH)2D3. The stereo image illustrates the position of the wild-type
phenylalanine (green) and mutant methionine (red) side chain in proximity to Leu-516 (yellow) in the b-5 sheet and Asp-338 (white) in the I-helix. Contact of
Phe-248 with the binding cavity is minor, suggesting that the effect of the mutation may be mediated through contact with Leu-516 in the b-5 sheet or a gating
effect at Asp-338. The 1a-OH-D3 substrate is shown inside the mesh framework of the binding cavity on the heme distal face. (b) The metabolism of 1a-OH-
D3 by the Leu-516-Val mutant is opposite in effect to the Phe-248-Met mutation and shows a preferential reduction in 27-hydroxylase activity and a minor
increase in the formation of a 24-hydroxylated product associated with reduced steric contact with substrate. (c) The enhanced 25-hydroxylase and reduced
27-hydroxylase activities associated with the Val-515-Leu (shown in the stereo view) and Val-515-Ile mutations in the b-5 hairpin appear to result from
increased steric contact with the substrate D-ring. (d) The Ile-514-Phe mutation results in a considerable loss of enzyme activity consistent with an unfavorable
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FIGURE 6 Continued.
steric conﬂict with the substrate A-ring, occlusion of the substrate access channel, or a distortion of the b-5 sheet through disruption of a structural link between
Thr-402 hydroxyl and Val-515 amide carbonyl. (e) The loss of activity seen with the Thr-402-Phe mutation is consistent with steric conﬂict with the substrate
A-ring, which would impede substrate access to the binding cavity and with disruption of the b-5 sheet through the loss of a structural hydrogen bond between
Thr-402 amide nitrogen and/or hydroxyl with Val-515 amide carbonyl. The loss of activity associated with the Asn-403-Thr mutation is consistent with the loss
of a heme-binding interaction to the A-ring propionate, which is stabilized by His-428 and conserved in CYP27A1 and CYP27B1 species homologs. (f)
Metabolic proﬁles seen for the Ser-404-Ala and Ser-404-Thr mutations. Disruption of a hydrogen bond to Asn-128 in the Ser-404-Ala mutant is hypothesized
to alter the orientation of the B-B9 loop and disrupt bound substrate orientations leading to better retention of 27-hydroxylation. The Ser-404-Thr mutation,
shown in the stereo view, maintains the contact with Asn-128, but the threonine methyl group results in a loss of enzyme activity by sterically disrupting
substrate access to the binding cavity.
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inﬂuences the orientation of bound substrate, possibly through
interaction with Leu-516 as described below.
Substrate contacts in the b-5 hairpin
In the CYP27A1 model, the b-5 hairpin contributed a large
and well-conserved hydrophobic surface to the binding cavity
and contained three potential substrate contact residues of
interest. The closest of these to the heme iron, Leu-516, was
conserved across species in the CYP27 and CYP11 isoforms
and in CYP24A1. A conservative mutation, Leu-516-Val,
was selected to probe the effect of steric size on substrate
contact, and HPLC analysis of the resulting 1a-OH-D3
metabolites shown in Fig. 6 b revealed that 27-hydroxylation
was preferentially reduced. The hydroxylation product ratio
shown in Table 2 was shifted from 14:49:36 (wild-type)
to 21:52:27 (Leu-516-Val) with only an 11% loss of total
activity. This was notably opposite to the effect of the F-helix
Phe-248-Met mutation and suggests that these two residues
act together to shape a substrate contact surface. The minor
increase in 24-hydroxylation was also in agreement with an
altered substrate orientation in the Leu-516-Val mutation.
The residue preceding Leu-516 is less conserved and seen as
valine in CYP27 isoforms and isoleucine in CYP24A1 and
the CYP11 isoforms. Two conservative mutations at Val-
515-Ile and Val-515-Leu were selected to probe the effect of
a larger side chain at this position. These mutations dra-
matically shifted the products toward 25-hydroxlation at the
expense of 27-hydroxylation (Fig. 6 c) and caused a 40%
increase in total enzyme activity (Table 2). This indicated
that the Val-515 side chain made a large contribution to the
orientation of bound 1a-OH-D3, and the docked substrate
shown in Fig. 6 c suggests that this occurs through contact
near the substrate D-ring. The third residue in the b-5 hairpin
is conserved as isoleucine in many CYP27A1 homologs,
threonine in CYP27B1, glycine in CYP24A1, leucine in
CYP11A1, and phenylalanine in CYP11B isoforms, and
may represent a ﬁnely tuned determinant of substrate spec-
iﬁcity. The mutation of this residue (Ile-514-Phe), com-
pletely shifted activity toward 25-hydroxylation (Fig. 6 d),
but abolished 94% of the total activity. Western analysis of
the Ile-514-Phe mutant revealed that it disrupts protein
expression (data not shown), suggesting that it may desta-
bilize correct folding of the b-5 hairpin and a functional
enzyme. Coincidentally, a similar effect was seen in the Thr-
402-Phe mutant described below.
Substrate contacts and heme-binding in
the b-3 sheet
The b-3a strand connects the ERR-triad and b-5 hairpin to
the heme-binding region. Along its length are structural,
heme-binding, and potential substrate contact residues
that are generally speciﬁc to a given CYP subfamily and
conserved across species. In the CYP27 family, the b-3a
strand starts with a PVVP motif in which the position of the
ﬁrst valine amide carbonyl hydrogen bonds to the amide
nitrogen of an aligned b-5 position (Val-517) in all 11
templates. This backbone interaction helps position the side
chain at the second valine position toward a substrate contact
near the heme A-ring. In the CYP2 templates, the amide
carbonyl at the second valine position also hydrogen bonds
with the 13 amide nitrogen to structurally stabilize the
heme-binding histidine at the 16 position. Following the
PVVP motif in CYP27A1 are three residues, Thr-402, Asn-
403, and Ser-404, which are as well conserved as Gly-Asn-
Ser in CYP27B1 and Phe-Thr-Thr in CYP24A1. The ﬁrst of
these in CYP27A1, Thr-402, was seen in the model to make
a potential hydrophobic contact through its methyl group
with the vitamin D A-ring. Conserved in human, mouse, and
rat, this interpretation is also consistent with valine in pig,
bovine, and zebraﬁsh. Additionally, computational docking
of 1a-OH-D3 in the binding cavity suggested that the
threonine hydroxyl interacts with the substrate 1a-hydroxyl
TABLE 2 Effect of mutations on the metabolism of 1a-OH-D3
1a,24-(OH)2D3 1a,25-(OH)2D3 1a,27-(OH)2D3 Total product Total activity 24:25:27 hydroxylation ratio
(ng) (ng) (ng) (ng) % % % %
Vector 36.9 6 1.4 32.7 6 4.2 13.1 6 1.0 83
pSG27A1 110.9 6 6.6 289.6 6 25.3 202.3 6 21.6 603 100 14 49 36
Phe-248-Met 99.5 6 6.5 213.5 6 20.5 199.2 6 29.8 512 83 15 42 43
Leu-516-Val 136.1 6 4.6 273.6 6 36.9 137.9 6 18.6 548 89 21 52 27
Vector 48.9 6 1.6 14.1 6 1.7 4.6 6 0.2 68
pSG27A1 103.5 6 2.9 298.6 6 1.8 263.8 6 2.1 666 100 9 48 43
Thr-402-Phe 50.4 6 3.0 21.6 6 2.1 7.4 6 0.7 79 2 13 63 24
Asn-403-Thr 47.6 6 2.6 13.2 6 2.1 4.4 6 1.8 65 0
Vector 17.5 6 3.1 8.5 6 0.8 4.9 6 1.2 31
pcDNA-27 58.4 6 12.7 264.7 6 67.0 259.1 6 65.0 582 100 7 46 46
Ser-404-Ala 57.9 6 1.9 240.6 6 10.2 81.8 6 3.7 380 63 12 66 22
Ser-404-Thr 30.5 6 0.3 74.6 6 2.0 68.8 6 2.0 174 26 9 46 45
Ile-514-Phe 17.2 6 0.3 41.0 6 1.4 4.5 6 0.2 63 6 0 100 0
Val-515-Ile 86.1 6 31.2 590.0 6 89.3 123.4 6 22.6 800 139 9 76 15
Val-515-Leu 118.4 6 6.4 584.8 6 27.2 87.0 6 4.8 790 138 13 76 11
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and its methyl interacts with the substrate C- and D-rings.
Interaction of a threonine hydroxyl in this vicinity with a
substrate hydroxyl has also been implicated in substrate
recognition in CYP27B1 (55). However, given the absolute
conservation of phenylalanine in CYP24A1, the Thr-402-
Phe mutation was chosen to see if a possible contact with the
cis-triene or changes in the shape of the binding cavity would
shift CYP27A1 activity toward 24-hydroxylation.
Similar to the effect of Ile-514-Phe, the Thr-402-Phe
mutation abolished 98% of the activity toward 1a-OH-D3
(Table 2) and produced only a trace of 25-hydroxylated
product (Fig. 6 e). As with the Ile-514-Phe mutant, Western
analysis revealed that the Thr-402-Phe mutation also disrupts
protein folding (data not shown). Given the proximity of
Thr-402 and Ile-514 and their location in the model, the
residual activity of these mutants may be attributed to effects
on substrate orientation, forcing bound substrate deep into
the cavity. The loss of detectable protein for these mutants
suggests that either phenylalanine mutation may sterically
disrupt a structural hydrogen bond between the b-5 and b3a
sheets. A structural interaction here between the b-sheets is
likely to be important in CYP27A1 since hydrogen bonding
between these two loci is found in 8/11 templates. This is
best seen from position 402 side chain (threonine) through a
crystallographic water to position 515 amide carbonyl in
CYP2C5, CYP2C9, and probably CYP2C8 and from position
402 side chain (serine) to position 514 amide carbonyl in
P450terp. In other templates, this interaction involves the
position 402 amide nitrogen to position 514 amide carbonyl
in P450eryF, to position 515 amide carbonyl in P450cam and
P450terp, and through a crystallographically conserved water
to position 515 amide carbonyl in CYP51, CYP2C5,
CYP2C9, and probably CYP2C8. In CYP119, an analogous
hydrogen bond links position 401 amide nitrogen to position
515 amide carbonyl. Given that the b-5 hairpin is also
secured by a hydrogen bond between the PVVP motif and
the position 517 amide, the principal effect of hydrogen
bonding at the Thr-402 position would be in the positioning
of Ile-514 residue. However, the involvement of the side-
chain hydroxyl (threonine) in this interaction is not crucial
in P450eryF or possible in half of the CYP27A1 species
homologs. Interestingly, the presence of threonine at position
514 in ﬁsh CYP27A1s and in the CYP27B1 homologs may
provide the reciprocal hydrogen bond interaction to the b-3a
strand.
All evidence points to the next b-3a residue, Asn-403,
being an accessory heme-binding residue. Designated earlier
as –2b3Arg, heme-binding with the A-ring propionate is
clearly evident in CYP2C5 (Asn-362 stabilized by121b3Arg
Thr-386) and in P450cam (Asp-297 stabilized by 123
b3Arg
Gln-322). In CYP27A1, heme-binding by Asn-403 would be
stabilized by 123b3Arg His-428, the latter being conserved
across 15 species. Structurally, the 2b3Arg position is con-
strained in the b-sheet through two backbone hydrogen
bonds (in 7/11 templates including CYP3A4) or a single
backbone hydrogen bond within the b-3a strand in the CYP2
family (4/11 templates). In all templates except P450terp, this
hydrogen bonding oriented the 2b3Arg side chain down-
ward and negated any possible substrate contact. Although a
serine or threonine at this position is only seen in 3/11
templates and only bound heme through a crystallographic
water in P450eryF, the Asn-403-Thr mutation in CYP27A1
was selected to examine whether threonine (conserved in
CYP24A1) could assume a heme-binding role. The resulting
loss of activity, shown in Fig. 6 e, suggests that Asn-403-Thr
cannot support a structurally viable heme-binding environ-
ment. Western analysis conﬁrmed that Asn-403-Thr disrupts
protein expression, and this is similar to the effect of a
mutation at an adjacent heme-binding and CTX residue,
Arg-405-Lys, which was shown spectrally to disrupt heme
incorporation (46).
The third b-3a residue examined in this study was1b3Arg
Ser-404. From its proximity to the binding cavity and the
heme A-ring, it is clear that Ser-404 is a potential substrate
contact residue. Computational docking of 1a-OH-D3 in the
binding cavity also suggested that the serine hydroxyl in-
teracts with the substrate 3b-hydroxyl. Ser-404 also appears
to be an integral structural component at the conﬂuence of
b-1, B-B9 loop, F-G loop, b-3a, and b-3b strands. This region
is structurally constrained by extensive b-sheet structure and
by heme-binding interactions through the b-3 arginine (Arg-
405) and B-B9 loop arginine (Arg-127). Rooted in this well-
deﬁned structure, the B-B9 loop made additional contacts
with the binding cavity and supported important determi-
nants of substrate speciﬁcity and substrate access in the B9-
helix, which are poorly represented in the crystallographic
templates. Interactions of the B-B9 loop with the b-3a strand
(in the vicinity of Ser-404) and b-3b strand occur in a
number of templates. This is best seen in P450bm3 as a triad
(1b3Arg Ser-322, 11BB9Arg Asn-70, and 118b3Arg Glu-
352), which is functionally conserved in CYP27A1 (across
at least seven species) as Ser-404, Asn-128, and Gln-423.
Interestingly, functionally similar interactions anchor the
B-B9 loop in CYP3A4 (1b3Arg Glu-374 to11BB9Arg Arg-106),
CYP2B4 (12BB9Arg Lys-100 amide nitrogen to 118b3Arg
Glu-387), and CYP2C5 (12BB9Arg Ser-99 amide to118b3Arg
Asp-383). The hydrogen bonding pattern was more elaborate
in P450cam (12
BB9Arg Cys-85, 14BB9Arg Phe-87 amide
carbonyl, 118b3Arg Gln-317), and P450terp (14
BB9Arg Ser76
amide carbonyl, 11b3Arg Thr-320, 118b3Arg Arg-337).
Within this context, two site-directed mutations were
engineered to explore the role of Ser-404 in CYP27A1. The
ﬁrst, Ser-404-Ala, was selected to structurally disrupt the
hydrogen bond with the B-B9 loop without sterically inter-
fering with substrate binding. As shown in Fig. 6 f, the
Ser-404-Ala mutation preferentially suppressed the 27-hy-
droxylation of 1a-OH-D3 and reduced the total enzyme
activity by 37%. This is consistent with steric effects of B-B9
loop on the bound substrate resulting from the loss a
structural hydrogen bond at Ser-404. The second mutation,
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Ser-404-Thr, was selected to probe the steric effect of a
methyl group with the substrate without disturbing the local
structure of the cavity. Surprisingly, this reduced overall
enzymatic activity by 64% (Fig. 6 f) without changing the
product ratio (wild-type 7:46:46 versus mutant 9:46:45). This
suggests that the unfavorable steric effect in Ser-404-Thr is
exerted during substrate entry, probably with the substrate C-
and D-rings, and not during the ﬁnal orientation of bound
substrate. These ﬁndings suggest that Ser-404-Thr retains the
substrate recognition function and structurally stabilized the
B-B9 loop and the bound substrate contact residues therein.
Substrate docking and molecular dynamics
The binding cavity was adequately proportioned to permit
manual docking of vitamin D3, 1a-OH-D3 A-ring con-
formers, cholesterol, or the bile acid precursor 5b-choles-
tane-3a,7a,12a-triol with little energy minimization. This
was conﬁrmed by computational docking that placed 1a-
OH-D3 in the binding cavity with c25 positioned 0.97 6
0.37 A˚ from its average position at a distance of 3.796 0.42
A˚ from the heme iron (9/10 structures). The substrate A-ring
was especially invariant in 8/10 of the docked structures and
not signiﬁcantly different from the manually docked posi-
tion, reﬂecting the fact that much of the substrate is a
structurally rigid seco-steroid. Most interestingly, the com-
putationally docked substrate sampled the conformational
space above the heme by rotating the substrate side-chain
bonds at c20-c22, c22-c23, c23-c24, and c24-c25. This al-
lowed c24, c25, and c26/27 to sample metabolically relevant
orientations near the hydroxylation site. The absence of the
1a-hydroxyl group in vitamin D substrates did not appear to
affect binding orientation (data not shown), but a comparison
of A-ring conformers suggested that the more planar b-chair
conformer, displaying an axial 1a-hydroxyl, gave a better ﬁt
(data not shown). The computational docking of 1a-OH-D2
was more precise, reﬂecting the smaller conformational
space afforded by the D22–23 in this substrate side chain. Nine
docked structures positioned c24 in a physiologically relevant
orientation 0.566 0.31 A˚ from its average position at a distance
of 4.37 6 0.36 A˚ from the heme iron. This was especially
exciting from a vitamin D standpoint since the 24-hydroxylation
of vitamin D2 is a unique enzymatic property of the enzyme (4).
Overall, we are conﬁdent that the manually docked substrate
adequately exempliﬁes a metabolically relevant conformation in
the active site, especially in the placement of the A-ring
hydroxyls as molecular ‘‘handles’’ interacting with Thr-402,
Ser-404, and other polar residues in the binding site.
We performedmolecular dynamics simulations using Insight
II on our docking model and observed structural conver-
gence as early as 100 ps with an RMSD of 1.22 A˚ averaged
over 479 alpha carbons. In light of the quick convergence,
there is no need to continue the molecular dynamics cal-
culations. We subsequently docked 1a-OH-D3 into this
structure and subjected it to an additional molecular dy-
namics simulation; only after 50 ps, it converged completely
and the RMSD decreased to 1.13 A˚. Using PROCHECK, we
found that 96.2% of residues are in allowed Ramachandran
plots.
The inner part of the binding cavity lay close to the b-3a
strand and was deﬁned by residues in the oxygen binding site
in the F- and I-helix, B-B9 and B9-C loops, and nonpolar
residues in the b-5 hairpin. The outer part of the binding
cavity and substrate access channel are deﬁned by residues in
the B-B9 loop, A9-, A-, B9- and F-helices, F-G loop, and the
b-1 and b-5 hairpin. Proton acceptor residues there are
presumed to help partition substrate into the active site and
orient it during the reaction cycle through interactions with
A-ring hydroxyl groups in vitamin D and 1a-OH-D3 and
with the 3-, 7-, and 12-hydroxyl moieties of bile acid
precursors. Additionally, a proton donor may be present to
coordinate with the c3 carbonyl of cholestenone, a preferred
substrate of CYP27A1 (6).
The outer part of the binding cavity near the b-sheets
contains an abundance of asparagines, glutamines, and
histidines, which suggests a structural network of hydrogen-
bonded residues with a multifaceted capacity to recognize
substrate. Quite intriguingly, the contact residues in the
b-sheets and A-helix are located at discrete positions (shown
in Fig. 1) and have identical side-chain orientations that are
independently determined by cytochrome P450 structure.
The cross species conservation of these discretely positioned
residues in all known vitamin D hydroxylases is summarized
in Fig. 7. What contributes to substrate speciﬁcity here is
the identity of the residue at each position. What determines
substrate contact is the size of the substrate, size of the
residue, and the extent to which side chains are displaced by
adjacent residues. What determine substrate recognition are
proximity, side-chain polarity, and the presence of functional
groups in the substrate. There are other substrate contact and
substrate recognition residues in the B9- and F-helices and in
the B-B9 and F-G loops and in the substrate access channel,
but in CYP27A1, there are no proton acceptor residues in the
F-G loop other than backbone carbonyls and a nonionized
Lys-259 or Arg-262 side chain.
Fig. 8 a shows the discretely conserved positions of
selected proton acceptors within range of the A-ring hydroxyl
groups on 1a-OH-D3 and Fig. 8 c shows the contribution of
binding cavity residues near the substrate side chain. It is
interesting to note that, for clarity, His-105, Asn-107, and
Cys-427 are not shown, but the histidine and cysteine are also
well placed to hydrogen bond with the 3b-hydroxyl and 1a-
hydroxyl groups, respectively. One of the more interesting
residues, Gln-85, is a VDDR-I locus (Q65H) and was con-
served in the A-helix across species in CYP27A1 and
CYP27B1. It has been implicated in substrate binding in
CYP27B1 (55), but given the opposite orientations of sub-
strate in these two enzymes, it seems unlikely that Gln-85
side-chain placement would be optimal for substrate recog-
nition in both. Instead, Gln-85 may fulﬁll a structural function,
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such as participation in the structural network in the outer part
of the binding cavity or blocking an access channel between
the A9- and A-helices. Alternatively, the Q65H polymorphism
in CYP27B1 may disrupt a structural hydrogen bond to
another discretely positioned residue, Thr-409, which is also
the site of a VDDR-I polymorphism (T409I). If Gln-85 does
coordinate with the 1a-hydroxyl group on 1a-OH-D3, the
model suggests that this function may be shared with Cys-427
and His-82. In fact, His-82 may be the more interesting re-
sidue because it is positioned to simultaneously form a
structural hydrogen bond with b-5 Ile-514 amide carbonyl and
contact the substrate 1a-hydroxyl group. This may explain
why His-82 is conserved across species in CYP11 isoforms,
rat CYP2J3, CYP2R1, and all mitochondrial vitamin D
hydroxylases (except murine Cyp27a1 where it is a proline).
The role of these discretely conserved proton acceptors in
bile precursor recognition is illustrated in Fig. 8 b, where
several were found to interact with the hydroxyl groups on
5b-cholestane-3a,7a,12a-triol. Given its docked orienta-
tion, residues such as Gln-423 or His-105 (not shown) are
well positioned to interact with the c3-hydroxyl, His-82 with
the c7-hydroxyl, and possibly a B-B9 loop backbone carbonyl
(e.g., Asp-129) with the c12-hydroxyl. These same residues
could also interact with the carbonyl of cholestenone.
Substrate access channel
Previously identiﬁed in P450cam (56), P450Bm3 (57), and
P450terp (58) and modeled into aromatase (59), the substrate
access channel connects the binding cavity to the protein
surface. In all but a few crystal structures, this opening is
hidden, even in the presence of bound substrate or inhibitor.
Molecular dynamics simulations in P450Bm3, P450cam, and
P450terp have examined the energetics of a number of
molecular trajectories out of the binding cavity (60,61) to
ﬁnd concealed channels, and a recent review (49) discussed
at least eight possible access routes or pathways: pw1,
between the heme and I-helix (possible oxygen channel);
pw2a, opening at F-G loop, B9-helix, b-1; pw2b, parallel to
b-3a and opening between the B-B9 loop and b-1; pw2c,
opening between the G- and I-helices and the B9-helix, B-C
loop; pw2d opening between the A- and A9-helices; pw2e
through the B-B9 and B-C9 loops; pw3, between the F- and
G-helices or at the E-F loop; and a solvent channel between
the E-, F-, and I-helices and b-5. Unfortunately, the
unveiling of a substrate access channel along one of these
pathways may be a transitory event coincident with substrate
penetration or the conformational changes associated with
reaction cycling and membrane association. Although the
most likely access route in most CYPs is pw2a (49), it is not
known whether different CYPs use different pathways,
whether a single CYP uses different channels for different
substrates, or whether separate pathways are used for
substrate access and product egress.
The geometry of the pw2a substrate access channel found
in the CYP27A1 docking model and shown in Fig. 8 d is not
ideal and exhibited some pw2b-type character similar to that
seen in CYP2C8 and P450Bm3. It was primarily occluded by
FIGURE 7 Cross-species variation of selected
residues predicted to orient toward substrate in
CYP27A1 and vitamin D hydroxylases. Based on
conserved structures and hydrogen bonding pat-
terns in 11 crystallographic templates, discrete
positions in the b-1 sheet, b-3b strand, and A9-
and A-helices have side chains oriented into the
substrate binding cavity near the mouth of the
pw2a substrate access channel. In CYP27A1, a
majority of these residues are polar, suggesting the
presence of a structurally important hydrogen
bonded network with a multifaceted capacity to
recognize substrate. This may be especially true of
His-82, which was predicted to simultaneously
hydrogen bond with the backbone of b-5 and the
1a-hydroxyl moiety of 1a-OH-D3 and is con-
served in CYPs 27A1, 27B1, 24A1, 2R1, and
2J3. Variation within species homologs suggests
small structural differences in an otherwise func-
tionally equivalent substrate contact region. The
numbered residue pertains to the ﬁrst species
homolog in each line as CYP27A1 (human, pig,
mouse, rabbit, rat, baboon, bovine, dog, chicken,
Xenopus, fugu, zebraﬁsh, rehesus monkey);
CYP27B1 (human, pig, mouse, rat, fugu);
CYP24A1 (human, pig, mouse, rat, guinea pig,
chicken, fugu, dog); CYP2R1 (human, mouse,
rat); CYP3A4 (human, pig); CYP2C11 (rat); and
CYP2J3 (rat). Dotted gaps indicate incomplete
sequence data for some species homologs.
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A9-helix Gln-75, F-helix Phe-256, and B-B9 loop Met-130,
possibly in part due to the uncertainties in modeling the F-G
loop and the B9-helix. Although the structure of this channel
does not affect how substrates are docked, it is desirable to
objectively reﬁne it to better understand substrate recognition
during binding. Our model revealed a cluster of 10 aromatic
residues above the heme that contributed a large hydrophobic
surface to the binding cavity and substrate access channel.
This cluster is surrounded by the F-G loop and included Trp-
133 (B9-helix), Tyr-253, and Phe-256 (F-helix), Trp-260 and
Trp-268 (F-G loop), Phe-267, Tyr-271, Trp-275 (G-helix),
and possibly Phe-279 and His-136, and may interact with
another cluster of aromatic residues in the A9-helix, the latter
possibly analogous to hydrophobic surface patches in
P450bm3 (57) and P450terp (58) postulated to be involved in
substrate recognition. Curiously, the former cluster corre-
sponded approximately to the location of a bound palmitic
acid in CYP2C8 (29) and an allosterically bound progesterone
near an analogous cluster of seven phenylalanine residues
(Phe cluster) in CYP3A4 (31). Additional modeling may be
necessary to fully understand the contribution of this aromatic
cluster to pw2a geometry and CYP activity.
To further characterize the contribution of the F-G loop to
the pw2a channel, we examined the model and site-directed
FIGURE 8 Predicted substrate binding orientations of (a) 1a-OH-D3 and (b) 5b-cholestane-3a,7a,12a-triol in the binding cavity of CYP27A1. This ﬁgure
shows potential substrate recognition residues (proton acceptors) capable of hydrogen bonding to the hydroxyl moieties of bound substrates in the vicinity of
the substrate access channel. (c) Contribution of I-helix and b-sheet residues to the surface of the binding cavity with 1a-OH-D3 side chain docked over the
heme A-ring. (d) The binding cavity of CYP27A1 showing a partially open pw2a-type substrate access channel and a putative pw3 egress channel between the
F- and G-helices near Met-334.
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mutagenesis and kinetic data of Murtazina et al., who showed
that F-G loop residues in CYP27A1 inﬂuence cholesterol
binding and 27-hydroxylation (62). Mutations in these sites
were postulated to disturb membrane binding and proton
availability during the reaction cycle and to restrict product
egress. Our interpretation is that selected mutations might also
disrupt the aromatic cluster above the heme and may variously
affect the shape of the binding cavity and/or the pw2a access
channel to affect the enzyme kinetics. Although the Murtazina
et al. model shows some similarity to the model presented
here, its major shortcoming is the lack of a binding cavity,
which we attribute to an incorrect positioning of Gly-145
(a VDDR-I and CTX residue) in the B9-C loop, Phe-240 in the
F-helix, and an improperly folded heme region.
The ﬁnding of an open pw3-type egress channel above the
I-helix and centered on Met-334 was intriguing. That this
channel is visible at all may result from uncertainty in the
positions and separation of the F- and G-helices or the position
of the E-F loop. If and how it should be closed in the model
will permit reﬁnement of local structure and has important
implications for the movement of molecules through the en-
zyme. Synchronization of substrate binding and metabolite
release through different channels is attractive because it would
sequentially expose both ends of vitamin D to hydroxylation,
in agreement with reports of CYP27A1 exhibiting both
25- and 1a-hydroxylase activities (63,64).
DISCUSSION
In this article, we present novel methodologies for modeling
cytochrome P450s, which were applied to model CYP27A1,
an important mitochondrial enzyme involved in bile acid
metabolism and the 25-hydroxylation of vitamin D. We used
this model to guide the selection of nine site-directed mutations
directed toward seven putative substrate contact residues
affecting the metabolism of the vitamin D prodrug, 1a-OH-D3.
Changes in activity and the regioselectivity of side-chain
hydroxylation were interpreted to result from conformational
changes affecting cavity shape, steric conﬂicts with bound
substrate, or disruption of a secondary heme-binding interac-
tion, though we cannot rule out that small differences in total
enzyme activity might be due to differences in enzyme
expression. The model was also used to explore, in silico,
broader aspects of substrate recognition in CYP27A1 and the
location of potential channels governing substrate access and
metabolite egress. In the remainder of the discussion, we have
highlighted the important aspects revealed by our study,
namely: a), the contribution of selected residues to the active
site structure and catalytic activity of CYP27A1 toward 1a-
OH-D3, and b), a modeling strategy based on the systematic
analysis of conserved hydrogen bonding patterns and structural
motifs in 11 CYP crystallographic templates.
The major objective of our metabolism studies was to
structurally probe putative substrate contacts in the binding
cavity of CYP27A1. In our opinion, one of the most inter-
esting ﬁndings in this study was that subtle changes in bound
orientation directly affect the ratio of 25- and 27-hydroxylated
products formed. The hydroxylation at c25 implied that the
substrate is bound deeper into the pocket. Mutations targeted
to the b-3a strand, b-5 hairpin, and F-helix changed the
structure predictably and altered CYP activity from positions
that have not been previously observed in patients with CTX,
VDDR-I, or any other P450 deﬁciency.
Mutations affecting the hydrophobic binding
cavity surface at the b-5 hairpin
The effect of the Phe-248-Met mutation on CYP27A1 acti-
vity was unique and shifted the ratio of 1a-OH-D3 metab-
olism toward 27-hydroxylation. Phe-248 was predicted to be
well within the F-helix and was clearly modeled into the top
of the substrate binding site. Whereas Phe-248 may contact
the substrate directly, its presence in CYP27B1 and CYP11
isoforms suggests that it plays a more generic function, such
as shaping the hydrophobic surface of the binding cavity
near Leu-516 in the b-5 hairpin. Phe-248 may deﬂect
Leu-516 away from the substrate so that the mutation to
methionine allows Leu-516 to have increased contact with
c27 to prevent deep penetration of substrate. The small de-
creases in total enzyme activity associated with the Phe-248-
Met and Leu-516-Val mutations may suggest that part of this
hydrophobic surface is also critical to the gating function of
Asp-338 in regulating proton access during the reaction
cycle via the adjacent solvent access channel. Interestingly,
the Phe-248-Lys mutation reported in a previous study
altered the regioselectivity of bile acid precursor hydroxyl-
ation by inducing a novel demethylase activity and the
formation of non-c27-oxidized and/or unsaturated products
(53). Consumption of protons during the reaction cycle could
make lysine a proton acceptor capable of directing a 27-
hydroxylated product toward demethylation. This could also
disrupt bound substrate orientations and/or Asp-338-regu-
lated proton transport resulting in altered product formation
and product release.
All of the b-5 hairpin mutations transformed CYP27A1
into a more efﬁcient 25-hydroxylase, shifting the ratio of
hydroxylation products toward 1a,25-(OH)2D3. In Leu-516-
Val, the smaller side chain had reduced contact with the
substrate, enlarged the binding cavity, allowed the deeper
penetration of substrate leading to 25-hydroxylation, and
may have decreased overall activity by disrupting Asp-338-
regulated proton transport. In our model, the side chain of
Val-515 made deep penetration of the substrate somewhat
unfavorable through steric contact with the c18 D-ring
methyl. A longer side chain could adopt rotomer conforma-
tions that reduce this contact, and this was seen in the
increased activity and deeper penetration of substrate in Val-
515-Ile and Val-515-Leu. The effect of the Ile-514-Phe
mutation is more complicated because the large loss of
activity can be interpreted as a large and unfavorable impact
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on the presumed substrate access channel. Resulting in a
preferential loss of 27-hydroxylated product, the residual
25-hydroxylase activity of the Ile-514-Phe mutation implied
that what little substrate was bound was deﬂected deep into
the active site. Whether this was caused by conformational
changes in the F-G loop, a productive interaction with the
vitamin D cis-triene, or a deﬂection of the adjacent Val-515
is not known. Overall, the mutations in the b-5 hairpin study
suggest that this structure forms a contoured hydrophobic
surface that affects substrate orientation.
Mutations affecting structure and substrate
contact in the b-3 sheet
In our model, it was found that the b-3a strand in CYP27A1
connected the b-5 sheet and B-B9 loop to an extended b-sheet
structure, bound the heme A-ring propionate from two
positions, and made signiﬁcant contact with bound substrate.
The Thr-402-Phe mutation severely impaired the activity of
the enzyme. We hypothesize that this occurred through the
loss of a structural link to the b-5 hairpin near Ile-514, which
disrupted protein stability and the loss of a contact with the
substrate 1a-hydroxyl. The Asn-403-Thr mutation appears to
have ablated activity by disrupting a heme-binding interaction
between the His-428-stabilized Asn-403 and the A-ring
propionate that disrupts protein stability. The loss of a proton
donor function associated with the Ser-404-Ala mutation
disrupted the contact with the substrate 3b-hydroxyl and the
B-B9 loop through the release of hydrogen bonding interac-
tions, the latter centered on Asn-128 and Gln-423 side chains.
The ensuing conformational change oriented bound sub-
strate deeper into the active site, preferentially disrupting
27-hydroxylation. A second mutation at this position, Ser-404-
Thr, did not inﬂuence bound substrate orientation toward
25- or 27-hydroxylation, but the methyl group sterically in-
terfered with binding and caused a signiﬁcant loss of activity.
Substrate recognition in the substrate
access channel
A survey of proton donors capable of recognizing the
hydroxyl groups on CYP27A1 substrates revealed a multi-
faceted hydrogen bonding network of conserved aspara-
gines, glutamines, and histidines in the extended b-sheet and
amino-terminal helices. It was found that these residues
occupied discrete positions and have side-chain orientations
that are independently determined by cytochrome P450 struc-
ture. Some of these residues may assist the partitioning of
substrates down a substrate access channel into the active site
through transient interactions with substrate hydroxyl groups
and presumably provide a mechanism for substrate speciﬁc-
ity by ﬁltering or selecting against previously hydroxylated
substrates.
Our model also revealed the existence of a previously
unrecognized aromatic cluster over the binding cavity. A
similar cluster in CYP3A4 formed a prominent hydrophobic
core, which was highly ordered and composed of residues
known to affect activity (31). In CYP27A1, this aromatic
cluster appears to contribute a large surface at the junction
of the binding cavity and a pw2a substrate access channel,
and contains residues shown in previous studies to affect
the kinetics of cholesterol hydroxylation (53,62).
Structural motif-based modeling methodology
In this study, we have used a new approach to homology
modeling which was based upon a strategy which is broadly
applicable to other cytochrome P450 proteins. We have used
the observed secondary structure and a systematic analysis of
hydrogen bonding patterns in 11 CYP crystal structures to
reﬁne the multisequence alignment and simplify the assign-
ment of secondary structure to a new CYP sequence. This
analysis revealed a number of residues and tertiary structural
motifs that are functionally conserved in most of the avail-
able CYP templates and probably in many other CYPs as
well. Although the function of some conserved elements has
been correctly deduced in other studies, for example the PGP
motif (42), our analysis revealed a high degree of commonality
in known CYP structures and drew attention to functionally
equivalent interactions that may be easily overlooked. These
structural motifs were used to guide the application of distance
constraints during energy minimization and molecular dynam-
ics. This strategy maximizes the likelihood of successfully
propagating known structure into regions that are difﬁcult to
model due to template heterogeneity. Finally, we have used
this approach to model CYP27A1 and explore the enigmatic
structure and location of access channels.
The ﬁnding of such a functionally conserved and highly
structured heme-binding region was unexpected and em-
phasizes the need for objective input during modeling. The
hydrogen bonding network around the propionates helped
position the B- and C-helices, B-B9 and B9-C loops, and
most of the b-sheet structure relative to the heme group. The
extensive hydrogen bonding network surrounding the ERR-
triad suggests an important structural core that stabilizes
adjacent structures and may, for some, change how protein
cofactor binding at the proximal heme face will be viewed.
This is probably also true for the conserved links between the
J- and K-helices and the K- and L-helices. The EH-gap motif
was an interesting ﬁnding since it helps delineate and
position the E-, G-, and H-helices and the E-F loop. The
incorporation of this motif in our model of CYP27A1
revealed a putative disulﬁde bond and raises the question of
the potential for formation of this structure in other CYPs.
The spatially conserved phenylalanine at the start of the
F-helix is an important alignment and modeling landmark, as
is the well-conserved aspartate at the start of the E-helix. The
unique aspects of cytochrome P450 structure revealed in this
modeling approach can now be used to predict and study the
binding pocket in other vitamin D-related hydroxylases.
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